MedTrace Logo

Stem Cell Migratory Activity: Prognostic Marker in Myocardial Ischemia

NCT01271309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2013-08-09

No results posted yet for this study

Summary

The present project aims to determine whether a deficit in migration of stem cells could be implicated in the failure to mount an adequate collateralization after Myocardial Infarction (MI) and thereby facilitate the development of post-ischemic heart failure (HF) and to dissect underlying molecular mechanisms. Furthermore, the investigators wish to determine the predictive value of stem cell migration assay in patients with MI.

Conditions

Sponsors & Collaborators

  • University Hospital of Ferrara

    collaborator OTHER

  • IRCCS Multimedica

    lead OTHER

Principal Investigators

  • Marco Valgimigli, MD · University Ferrara Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-08-31
Completion
2013-07-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01271309 on ClinicalTrials.gov